10-Q · May 13, 2026
BeyondSpring Inc. reported a net loss of $6.7 million for Q1 2026, a notable decrease from a $1.2 million gain in Q1 2025 that included a one-time gain of $7 million from the sale of subsidiary interests. The company…
Earnings analysis · 10-Q
BYSI earnings analysis
Filed August 14, 2026 · Our reading of the company's report
The latest report
The 10-Q does not provide the income statement, balance-sheet, cash-flow or segment figures needed to assess quarterly financial trends from the supplied filing extract. The principal filing signal is heightened…
Read full summary
The 10-Q does not provide the income statement, balance-sheet, cash-flow or segment figures needed to assess quarterly financial trends from the supplied filing extract. The principal filing signal is heightened financing risk: BeyondSpring reports operating losses and negative operating cash flows since inception, expects no significant revenue for the foreseeable future, and says additional capital is required to continue operations. A new CEO assumed office effective July 1, 2026, adding execution and retention risk, although controls were effective as of June 30, 2026.
How we read each report
Our analysis across the last few reports.
Our model's reading of each filing, not the share price or the market's reaction. Annual and quarterly reports each occupy one position.
What stood out
-
Controls Remained Effective
Management concluded that disclosure controls and procedures were effective as of June 30, 2026. It also reported no change during the quarter ended June 30, 2026 that materially affected, or was reasonably likely to materially affect, internal control over financial reporting.
-
No Material Legal Proceedings
BeyondSpring reported no legal proceedings that would individually or collectively have a material adverse effect on its business, financial condition, results of operations or cash flows as of August 14, 2026.
What to watch
-
Going-Concern Financing Dependence
The company states that it has incurred operating losses and negative operating cash flows since inception and does not expect to generate significant revenue for the foreseeable future. It says continued operations depend on additional capital, with no assurance that financing will be available on acceptable terms; equity issuance could dilute existing shareholders and debt would increase liabilities and future cash commitments.
-
CEO Transition and Talent Risk
Min Qiu began serving as Chief Executive Officer effective July 1, 2026, creating a newly identified key-personnel risk. The company states that losing Mr. Qiu or other key employees, or failing to attract qualified personnel, could delay or prevent research, development, regulatory and business objectives.
Management's outlook
The filing provides no quantified revenue or EPS outlook. Management states it does not expect significant revenue for the foreseeable future and expects significant operating losses to continue, but no numeric guidance is provided.
Earlier filings 4
10-K · March 25, 2026
BeyondSpring’s 2025 10-K emphasizes Plinabulin as the company’s strategic focal point after a positive Phase 3 (DUBLIN-3) readout; the company reports no product revenue and remains a clinical-stage biopharma.…
10-Q · November 12, 2025
BeyondSpring reported no revenue for Q3 2025 and narrowed its continuing operations loss (loss from operations) to $(1,790) in Q3 2025 from $(2,358) in Q3 2024. EPS improved to $(0.04) in Q3 2025 from $(0.05) in Q3…
10-Q · August 13, 2025
BeyondSpring reported no revenue for Q2 2025 and posted a per-share loss of $(0.04), an improvement from $(0.10) in Q2 2024. Operating loss narrowed to $(1,949) from $(2,641) year-over-year, helped by a $865 reduction…
This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.